Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Checklists · CHEERS checklist

CHEERS 2022 Has 28 Items, and Its Own Task Force Warns Against Using It as a Quality Score

CHEERS 2022 is the current ISPOR-endorsed reporting standard for health economic evaluations — 28 items across cost-effectiveness, cost-utility and related analyses. It replaces CHEERS 2013 and explicitly should not be used to score a study’s methodological quality.

Pubrica AcademyWritten by the medical writing and biostatistics teams Reviewed byPubrica biostatistics team Published8 October 2026 Last checked8 October 2026 Reading time7 minutes

CHEERS stands for Consolidated Health Economic Evaluation Reporting Standards. The CHEERS 2022 ISPOR Good Research Practices Task Force, led by Don Husereau and Michael Drummond, published the update simultaneously in Value in Health, BMJ, PharmacoEconomics, BMC Medicine and Clinical Therapeutics in 2022.

What it is

Husereau D, Drummond M, Augustovski F, et al.; CHEERS 2022 ISPOR Good Research Practices Task Force. “Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement.” PharmacoEconomics 2022;40:601–609.

CHEERS 2022 updates the 2013 checklist because health-economic methods have advanced, because the 2013 version was sometimes misused to score study quality in systematic reviews (which the task force says can mislead), and because of growing interest in analysis plans, transparent modelling, equity and distributional effects, and patient/public engagement in study design.

Health economic evaluations broadly: cost analyses, cost-effectiveness, cost-utility, cost-minimisation and cost-benefit analyses, and extended evaluations incorporating equity considerations — whether based on decision-analytic modelling, patient-level data, or both. It explicitly excludes budget impact analyses and constrained optimisation studies, which have their own separate guidance.

Is this the right tool?

Use it when

Researchers reporting a health economic evaluation, while writing and at submission; peer reviewers and editors assessing completeness; and HTA bodies using it as reporting guidance when reviewing submitted economic evidence.

Not the right tool when

The task force explicitly warns against using CHEERS (2013 or 2022) as a numerical quality-scoring instrument in systematic reviews — it assesses reporting completeness, not methodological rigour. It does not apply to budget impact analyses, and it is not conduct guidance (for that, see the Second Panel on Cost-Effectiveness in Health and Medicine).

The checklist

28 items under the statement’s own section headers.

Title through introduction

ItemWhat it requires
1. TitleIdentify the report as an economic evaluation and name the interventions compared.
2. AbstractA structured summary: context, key methods, results, alternative analyses.
3. Background and objectivesStudy context, research question, relevance to policy or practice.

Methods (1 of 2)

ItemWhat it requires
4. Analysis planWhether a pre-specified plan was developed and how to access it.
5. Study populationRelevant population characteristics.
6. Setting and locationContextual information that may affect findings.
7. ComparatorsInterventions compared and the rationale for their selection.
8. PerspectiveThe analytic perspective adopted and why.
9. Time horizonThe time horizon and its rationale.
10. Discount rateRate(s) applied and rationale.
11–13. OutcomesSelection, measurement and valuation of outcomes.

Methods (2 of 2)

ItemWhat it requires
14–15. Resources and costsMeasurement/valuation of resource use, and currency/price date/conversion.
16–17. ModellingModel rationale, description, public availability, analytics and validation.
18. HeterogeneityMethods for estimating how results differ across subgroups.
19. Distributional effectsHow impacts are distributed, or equity adjustments made.
20. UncertaintyMethods used to characterise uncertainty.
21. EngagementHow patients, the public or stakeholders were involved.

Results, discussion and other

ItemWhat it requires
22. Study parametersAll analytic input values, with references and justification.
23. Main resultsMean costs and outcomes, summarised with an overall measure (e.g. ICER).
24–25. Uncertainty and engagement effectsHow uncertainty and any stakeholder engagement affected the findings.
26. Findings and limitationsKey findings, limitations, equity issues, implications.
27–28. Funding and conflictsFunding source and role; conflicts of interest per ICMJE.

Applying it, with the evidence

The CHEERS 2022 task force itself reports that in a convenience sample of 50 published articles that cited the original checklist, only 42% (95% CI 28–56%) actually used it appropriately. That means more than half of authors who clearly intended to follow a health-economics reporting standard, and said so in print, still did not apply it correctly — a direct illustration of how easy it is for a cost-effectiveness analysis to look compliant on its face while still omitting the structured detail a payer or guideline body needs to trust the stated cost-per-outcome figure.

CHEERS is the standard for cost-effectiveness, cost-utility, cost-benefit and model-based economic evaluations of drugs, devices, vaccines and public-health interventions. HTA bodies, ISPOR and the journals that co-published the 2022 update (Value in Health, PharmacoEconomics, European Journal of Health Economics) all treat it as the field’s reporting backbone.

In order

Identify the evaluation typeCost analysis, cost-effectiveness, cost-utility, cost-benefit or distributional/equity-focused, since this determines which items (e.g. 19) matter most.
Use the 28 items as a drafting outlineJustify perspective (8), time horizon (9) and discount rate (10), not just state them.
Document any decision-analytic model fullyItems 16–17, including validation and public availability.
Address items 18–21 explicitlyEven when the answer is “not undertaken” — reviewers now expect these addressed given the 2022 update.
Submit the completed CHEERS 2022 checklistMapping each item to a manuscript page or section.

Where it goes right

With it — no verifiable example found

Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.

Common mistakes

  • Perspective and discount rate are often stated without justification. Items 8 and 10 ask for the rationale, not just the choice.
  • Items 4 and 21 are new 2022 emphases and the most often skipped. Analysis plan and stakeholder engagement did not exist as items in 2013.
  • Never use CHEERS as a quality score. The task force explicitly calls this out as a documented misuse.

Where it falls short

Without it — the task force’s own compliance check

Inside the CHEERS 2022 statement itself, the task force reports that in a convenience sample of 50 articles citing the original CHEERS checklist, only 42% (95% CI 28–56%) used it appropriately — meaning a majority of papers that cited CHEERS as their reporting standard still failed to apply it correctly. The task force also explicitly warns the checklist should never be used to score study quality, only reporting completeness.

Husereau D, Drummond M, Augustovski F, et al. “Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.” European Journal of Health Economics, 2022;23:1309–1317. doi.org/10.1007/s10198-021-01426-6.

Common questions

Yes — new evaluations should use 2022, which adds analysis plans, modelling transparency, distributional/equity effects and stakeholder engagement.

No — the task force explicitly calls this a misuse; it measures reporting completeness, not rigour.

No. The task force excludes these and constrained optimisation studies; separate guidance applies.

References and sources

  1. Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement. PharmacoEconomics 2022;40:601–609. read 8 October 2026. doi.org/10.1007/s40273-021-01112-8
  2. EQUATOR Network. CHEERS 2022 checklist. read 8 October 2026. equator-network.org

Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 8). CHEERS 2022 Has 28 Items, and Its Own Task Force Warns Against Using It as a Quality Score. Pubrica. https://pubrica.com/insights/checklist/cheers-health-economic-evaluation-checklist/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.

How Pubrica helps

Pubrica’s health economics and market access team builds the CHEERS 2022 checklist around the actual model or trial-based analysis, including the newer analysis-plan and equity items most manuscripts still miss.

Find something else

Search the rest of the Academy.

Open with no account. Type what you are working on, or open the full library to filter by category, sub-topic or resource type.

Send the model or analysis before the write-up.

A scoping read costs nothing and takes two business days. You get a written view of what the work needs and who would hold it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.